Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Care | Research article

Multidimensional pruritus assessment in hemodialysis patients

Authors: Nese Altınok Ersoy, İmatullah Akyar

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Pruritus is a distressing, life-limiting symptom in chronic renal failure, affecting 40% of patients. This study aimed to determine uremic pruritus prevalence and investigate the multidimensional impact on hemodialysis patients.

Methods

This descriptive study was performed between March and June 2016. The study included 181 patients undergoing hemodialysis session, who reported pruritus in the prior month. Data were collected using the 5-D Itch Scale, which assesses pruritus based on 5 dimensions, i.e., degree, duration, direction, disability, and distribution, with a total score ranging from 5 (no itching) to 25 (maximum severity).

Results

Pruritus prevalence was 49.3%. Patients had a mean score of 13.97 ± 4.11 (moderate severity). The daily duration was 6–12 h (40.3%), with direction “a little bit better but still present” (38.7%) and distribution on the “back, upper arms, chest, and abdomen.” Patients sleep, social life/leisure time, housework and errand were impacted “occasionally”. The score was higher in patients aged ≥65 years, those on hemodialysis for ≥15 or more years, and those undergoing afternoon hemodialysis. The duration of itching was significantly shorter in employed patients.

Conclusion

Assessment and management of itching symptoms in chronic renal failure are a clinical priority both for patients and for health care professionals. The results of this study highlight the importance of multidimensional assessment and support the need for development of standardized and patient-specific symptom management.
Literature
1.
go back to reference Pisoni RL, Wikström B, Elder SJ, Akizawa T, Asano Y, Keen ML, Saran R, Mendelssohn DC, Young EW, Port FK. Pruritus in haemodialysis patients: international results from the Dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495–505. https://doi.org/10.1093/ndt/gfl461.CrossRefPubMed Pisoni RL, Wikström B, Elder SJ, Akizawa T, Asano Y, Keen ML, Saran R, Mendelssohn DC, Young EW, Port FK. Pruritus in haemodialysis patients: international results from the Dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495–505. https://​doi.​org/​10.​1093/​ndt/​gfl461.CrossRefPubMed
12.
go back to reference Alpar R. Applied statistics and the validity and reliability: examples from sports, health and education science. Ankara: Detay Publishing; 2014. Alpar R. Applied statistics and the validity and reliability: examples from sports, health and education science. Ankara: Detay Publishing; 2014.
22.
go back to reference Jamal AS. Pruritus among end-stage renal failure patients on hemodialysis. Saudi J Kidney Dis Transpl. 2000;11(2):181–5.PubMed Jamal AS. Pruritus among end-stage renal failure patients on hemodialysis. Saudi J Kidney Dis Transpl. 2000;11(2):181–5.PubMed
24.
go back to reference Terzi Ö. Evaluation of pruritus problem in hemodialysis patients. Internal Medicine Master Thesis. On Dokuz Mayıs University: Samsun, 2009. Terzi Ö. Evaluation of pruritus problem in hemodialysis patients. Internal Medicine Master Thesis. On Dokuz Mayıs University: Samsun, 2009.
27.
go back to reference Göksütün D. The relationship between uremic pruritus and 25-hdyroxy vitamin D in hemodialysis patients. In: Department of Internal Medicine. Başkent University: Ankara: Master Thesis; 2014. Göksütün D. The relationship between uremic pruritus and 25-hdyroxy vitamin D in hemodialysis patients. In: Department of Internal Medicine. Başkent University: Ankara: Master Thesis; 2014.
28.
go back to reference Vila T, Gornmer J, Scates AC. Role of gabapentin in the treatment of uremic pruritus. Ann Pharmacother. 2008;42(7–8):1080–4.CrossRef Vila T, Gornmer J, Scates AC. Role of gabapentin in the treatment of uremic pruritus. Ann Pharmacother. 2008;42(7–8):1080–4.CrossRef
30.
go back to reference Tessari G, Dalle Vedove C, Loschiavo C, Tessitore N, Rugiu C, Lupo A, Girolomoni G. The impact of pruritus on quality of life of patients undergoing dialysis: a single-center cohort study. J Nephrol. 2009;22(2):241–8.PubMed Tessari G, Dalle Vedove C, Loschiavo C, Tessitore N, Rugiu C, Lupo A, Girolomoni G. The impact of pruritus on quality of life of patients undergoing dialysis: a single-center cohort study. J Nephrol. 2009;22(2):241–8.PubMed
35.
go back to reference Sezen A. Hemodialysis. In: Sezen A, editor. Dialysis handbook. Ankara: Nobel tip -Publisher; 2003. p. 57–71. ISBN: 978-975-420-981-5. Sezen A. Hemodialysis. In: Sezen A, editor. Dialysis handbook. Ankara: Nobel tip -Publisher; 2003. p. 57–71. ISBN: 978-975-420-981-5.
Metadata
Title
Multidimensional pruritus assessment in hemodialysis patients
Authors
Nese Altınok Ersoy
İmatullah Akyar
Publication date
01-12-2019
Publisher
BioMed Central
Keywords
Care
Pruritus
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1234-0

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.